Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 2nd October 2012
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Update on Bluetongue vaccination
Regulation change for Bluetongue-free areas

Bluetongue laws have changed for England and Scotland, and are set to change for Wales, to allow the use of approved inactivated vaccines in Bluetongue-free areas, on the basis of Veterinary Risk Assessments.

In England, the Bluetongue (Amendment) Regulations 2012 came into effect last month (24 August) to permit the use of inactivated Bluetongue vaccines in Bluetongue-free areas. A General Licence has been issued to protect against Bluetongue serotypes 1, 2, 4 and 8.

Scotland's Bluetongue (Scotland) Order 2012 came into effect at the same time as England and permits inactivated Bluetongue vaccinations against all serotypes within Bluetongue-free areas.

Next week (10 October), the Bluetongue (Wales) (Amendment) Regulations 2012 will come into effect, permitting the use of inactivated Bluetongue vaccinations in Bluetongue-free areas against all serotypes.

The use of voluntary vaccination against Bluetongue remain illegal in both Northern Ireland and the Republic of Ireland.

Regulations for live attenuated vaccines remain unaltered, and must not be used due to the risk of reversion to virulence and subsequent disease spread. Live attenuated vaccines do not have marketing authorisations for use in the UK.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.